Quarterly Result13 Nov 2026, 08:42 pm
Genesys International Declares Unaudited Q2 FY27 Results
AI Summary
Genesys International Corporation Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, along with a Limited Review Report from the statutory auditors. Additionally, the company approved the grant of 3,65,000 Employee Stock Options under the Genesys Employee Stock Option Scheme, 2022, with an exercise price ranging from Rs. 70 to Rs. 100 per equity share.
Key Highlights
- Unaudited standalone and consolidated financial results for Q2 FY27 declared.
- Board approved the financial results and limited review report.
- 3,65,000 Employee Stock Options granted to eligible employees.
- ESOP exercise price ranges from Rs. 70 to Rs. 100 per share.
- Results prepared in compliance with Indian Accounting Standards (Ind AS).
Price Impact
More from GENESYS